Which UK regions had the highest rates of vaccinated people among flu hospital admissions this season?
Executive summary
Available sources do not report a regional breakdown of “rates of vaccinated people among flu hospital admissions” for this season; reporting instead gives national vaccine effectiveness estimates (children 70–75%, adults 30–40%) and broad vaccine uptake figures (e.g., 74.4% in people 65+ and ~39–40% in some at‑risk groups) [1] [2] [3]. No source in the supplied set lists which UK regions had the highest proportions of vaccinated patients among those admitted for flu this season — that data is not found in current reporting.
1. What the supplied reporting actually measures — and what it doesn’t
Public summaries cited here focus on vaccine effectiveness (reduction in hospital attendance or admission) and overall uptake by demographic cohorts, not the share of admitted patients who had been vaccinated by UK region. UKHSA/press reporting gives effectiveness estimates — children 70–75% lower risk of hospital attendance if vaccinated and adults about 30–40% lower risk — while surveillance bulletins show uptake figures such as 74.4% for those aged 65+ and around 39–40% for some under‑65 clinical risk groups [1] [2] [3]. None of the articles or government pages in the search results publish regional breakdowns of vaccination status among hospitalized flu patients (not found in current reporting).
2. Why people sometimes look for “vaccinated share of admissions” — and the limits of that metric
Journalists and public health officials sometimes report the percent of hospitalised patients who were vaccinated because it can appear to show vaccine performance in real‑world settings. But that proportion is highly sensitive to who was offered and accepted vaccination (coverage), who is at highest risk (age, comorbidities), and the vaccine’s effectiveness — so a high percentage of vaccinated people among admissions can reflect high coverage in the vulnerable, not vaccine failure. The supplied sources emphasise effectiveness and uptake separately — for example, Public Health Scotland highlights strong protection against severe disease while noting rising activity, and GOV.UK surveillance shows uptake by age/cohort [2] [3].
3. What the sources say about effectiveness and uptake that matters for interpretation
Early UKHSA and related reporting in these items state the vaccine gives “strong protection”: children vaccinated are 70–75% less likely to attend or be admitted with flu; adults are about 30–40% less likely [1] [2]. Separately, the GOV.UK surveillance bulletin reports uptake through mid‑January 2025 as 74.4% for people 65+ and roughly 39–40% for some under‑65 clinical risk groups and pregnant women [3]. Those two facts together explain why the composition of hospital admissions by vaccination status could vary sharply by age and region: older groups have higher uptake and better ascertainment in reporting, while younger at‑risk groups have lower uptake [3].
4. Why regional comparisons aren’t present in these materials
The documents provided are national guidance, news reporting and surveillance bulletins that prioritise national or Scotland‑level trends, cohort uptake targets and vaccine programme logistics (start dates and completion windows), not a granular regional tabulation of vaccination status among admissions [4] [5] [6] [2]. Public Health Scotland and NHS England releases point to national programme aims and early effectiveness signals, but the set does not include the kind of NHS Trust or UKHSA dataset that would allow ranking regions by the vaccinated share of flu inpatients (not found in current reporting).
5. How you could get the precise regional breakdown
To answer your original question authoritatively, request or consult: (a) the UKHSA or devolved public‑health agency’s detailed hospital surveillance dataset for this season, (b) NHS England weekly situation reports that include vaccination status of admitted cases by NHS region or trust, or (c) freedom‑of‑information requests to regional health authorities. The supplied sources point to where those data typically live (UKHSA / Public Health Scotland / NHS England surveillance) but do not themselves contain the regional admissions‑by‑vaccination tables [2] [3] [5].
6. Bottom line for readers
Current reporting in the supplied documents shows the vaccine is reducing hospital attendance and admission (children ~70–75%, adults ~30–40%) and gives national uptake snapshots (e.g., 74.4% for 65+), but it does not identify which UK regions had the highest rates of vaccinated people among flu hospital admissions this season — that detail is not available in these sources [1] [2] [3]. If you want a regional ranking, the appropriate next step is to check UKHSA/NHS England regional surveillance releases or ask those agencies for admissions‑by‑vaccination‑status tables.